AdraCard
AdraCard develops a proprietary, credit card-sized powder nasal spray platform for rescue medications used in sudden medical emergencies. Rescue medication only works if it is with the patient when the crisis occurs. By designing a device that fits seamlessly into a phone case, wallet, or pocket, AdraCard aims to solve the core problem of non-carriage and complacency, enabling constant access to life-saving medication in conditions such as anaphylaxis, seizure clusters, opioid overdose, hypoglycaemia, and migraine, beginning with adrenaline for anaphylaxis as its lead indication.
Industries
Nr. of Employees
small (1-50)
AdraCard is currently seeking investment
AdraCard is seeking a seed investment in the range of 5m-20m
Products
Proprietary adrenaline drug delivery platform
A device-platform enabling accessible, stable, and easy administration of adrenaline for anaphylaxis in daily life settings.
Proprietary adrenaline drug delivery platform
A device-platform enabling accessible, stable, and easy administration of adrenaline for anaphylaxis in daily life settings.
Expertise Areas
- Anaphylaxis treatment innovation
- Drug-device development
- Medical device usability
- Emergency drug delivery systems
Key Technologies
- Drug delivery systems
- Temperature-stable medication formulations
- Needle-free or user-friendly administration technology
Key People
Founder & CEO
Founder & CTO
Head of Quality and Reg
Head of Product Development
Advisory Board Member
Advisory Board Member
Founder & CEO
Founder & CTO
Head of Quality and Reg
Head of Product Development
Advisory Board Member
Advisory Board Member